References
- Annas, G., and S. Elias. 1999. “Thalidomide and the Titanic: Reconstructing the Technology Tragedies of the Twentieth Century.” American Journal of Public Health 89 (1): 98–101.
- BBC. 2012. German Thalidomide Maker Gruenenthal Issues Apology. http://www.bbc.co.uk/news/health-19443910
- Daemmrich, A. 2002. “A Tale of Two Experts: Thalidomide and Political Engagement in the United States and West Germany.” Social History of Medicine 15 (1): 137–158.
- Franks, M. E., G. R. Macpherson, and W. D. Figg. 2004. “Thalidomide.” The Lancet 363(9423): 1802–1811.
- Heidegger, M. 1973. Art and Space. Man and World 6 (1): 3–8.
- Heidegger, M. 1993a. “On the Essence of Truth.” In Martin Heidegger: Basic Writings. 2nd ed, edited by D. F. Krell, 111–138. San Francisco: Harper Collins.
- Heidegger, M. 1993b. ‘The Origin of the Work of Art.’ In Martin Heidegger: Basic Writings. 2nd ed, edited by D. F. Krell, 143–212. San Francisco: Harper Collins.
- Heidegger, M. 1996. Being and Time. (Translated by J. Stambaugh) New York: State University of New York Press.
- Hughes, B. 1999. “The Constitution of Impairment: Modernity and the Aesthetic of Oppression.” Disability & Society 14 (2): 155–172.
- Hughes, B. 2000. “Medicine and the Aesthetic Invalidation of Disabled People.” Disability & Society 15 (4): 555–568.
- Kämper, O. 2012. Too Little, Too Late, Say Thalidomide Victims. Deutsche Welle. http://www.dw.de/too-little-too-late-say-thalidomide-victims/a-16214497
- McBride, W. 2004. “Health of Thalidomide Victims and Their Progeny.” The Lancet 363 (9043): 169–169.
- Melchert, M., and A. List. 2007. “The Thalidomide Saga.” International Journal of Biochemistry and Cell Biology 39 (7–8): 1489–1499.
- Oliver, M. 1990. The Politics of Disablement. London: Macmillan.
- Overboe, J. 1999. “Difference in Itself’: Validating Disabled People’s Lived Experience.” Body & Society 5 (4): 17–29.
- Schillmeier, M. 2007. Dis/Abling Practices: Rethinking Disability. Human Affairs 17 (2): 195–208.
- Schillmeier, M. 2008. “Time-Spaces of in/Dependence and Dis/Ability.” Time and Society 17 (2/3): 215–231.
- Schillmeier, M. 2010. Rethinking Disability: Bodies, Senses, Things. New York: Routledge.
- Siebers, T. 2006. “Disability Aesthetics.” Journal for Cultural and Religious Theory 7 (2): 63–73.
- Siebers, T. 2010. Disability Aesthetics. Ann Arbor: University of Michigan Press.
- The Thalidomide Trust. 2011. Securing Our Future: The Disability and Health Costs of UK Thalidomide-Affected People. Eaton Scoton: National Advisory Committee to the Thalidomide Trust.
- Timmermans, S., and V. Leiter. 2000. “The Redemption of Thalidomide: Standardizing the Risk of Birth Defects.” Social Studies of Science 30 (1): 41–71.
- Titchkosky, T. 2000. “Disability Studies: The Old and the New.” Canadian Journal of Sociology 25 (2): 197–224.
- Titchkosky, T. 2007. Reading and Writing Disability Differently: The Textured Life of Embodiment. Toronto: University of Toronto Press.
- von Moos, R., R. Stolz, T. Cerny, and S. Gillessen. 2003. “Thalidomide: From Tragedy to Promise.” Swiss Medical Weekly 133: 77–87.
- Watson, S. 2006. “Heidegger, Paul Klee, and the Origin of the Work of Art.” The Review of Metaphysics 60 (2): 327–357.